DE69902234T2 - Matrixprotein enthaltende zusammensetzungen zur wundheilung - Google Patents

Matrixprotein enthaltende zusammensetzungen zur wundheilung

Info

Publication number
DE69902234T2
DE69902234T2 DE69902234T DE69902234T DE69902234T2 DE 69902234 T2 DE69902234 T2 DE 69902234T2 DE 69902234 T DE69902234 T DE 69902234T DE 69902234 T DE69902234 T DE 69902234T DE 69902234 T2 DE69902234 T2 DE 69902234T2
Authority
DE
Germany
Prior art keywords
matrix protein
protein compositions
healing
wounds healing
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69902234T
Other languages
English (en)
Other versions
DE69902234D1 (de
Inventor
Stina Gestrelius
Lars Hammarstroem
Petter Lyngstadaas
Christer Andersson
Ivan Slaby
Tomas Hammargren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Straumann AG
Original Assignee
BIORA BIOEX MALMOE AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIORA BIOEX MALMOE AB filed Critical BIORA BIOEX MALMOE AB
Application granted granted Critical
Publication of DE69902234D1 publication Critical patent/DE69902234D1/de
Publication of DE69902234T2 publication Critical patent/DE69902234T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69902234T 1998-02-27 1999-02-26 Matrixprotein enthaltende zusammensetzungen zur wundheilung Expired - Lifetime DE69902234T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK27098 1998-02-27
US8155198P 1998-04-13 1998-04-13
DKPA199801328 1998-10-16
PCT/IB1999/000337 WO1999043344A2 (en) 1998-02-27 1999-02-26 Matrix protein compositions for wound healing

Publications (2)

Publication Number Publication Date
DE69902234D1 DE69902234D1 (de) 2002-08-29
DE69902234T2 true DE69902234T2 (de) 2003-03-27

Family

ID=27220558

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69910622T Expired - Lifetime DE69910622T2 (de) 1998-02-27 1999-02-26 Matrixprotein enthaltende Zusammensetzungen für entzündliche und infektiöse Zustände
DE69902234T Expired - Lifetime DE69902234T2 (de) 1998-02-27 1999-02-26 Matrixprotein enthaltende zusammensetzungen zur wundheilung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69910622T Expired - Lifetime DE69910622T2 (de) 1998-02-27 1999-02-26 Matrixprotein enthaltende Zusammensetzungen für entzündliche und infektiöse Zustände

Country Status (19)

Country Link
EP (2) EP1059934B1 (de)
JP (2) JP5024866B2 (de)
KR (1) KR20010041408A (de)
CN (1) CN1248734C (de)
AT (2) ATE220918T1 (de)
AU (1) AU740468B2 (de)
BR (1) BR9908182A (de)
CA (2) CA2322215C (de)
DE (2) DE69910622T2 (de)
DK (2) DK1153610T3 (de)
ES (2) ES2204804T3 (de)
HK (1) HK1030880A1 (de)
HU (1) HUP0101710A2 (de)
IL (1) IL137869A0 (de)
IS (1) IS5591A (de)
NO (1) NO20004282L (de)
PL (1) PL202536B1 (de)
SK (1) SK12362000A3 (de)
WO (1) WO1999043344A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096740A1 (en) 1999-03-10 2003-05-22 Lars Hammarstrom Matrix protein compositions for induction of apoptosis
US7304030B2 (en) 2000-06-20 2007-12-04 Biora Ab Matrix protein composition for dentin regeneration
ES2334977T3 (es) * 2000-06-20 2010-03-18 Institut Straumann Ag Composiciones de proteinas de la matriz para la regeneracion de dentina.
ATE374048T1 (de) * 2001-02-23 2007-10-15 Biora Bioex Ab Verwendung von matrixprotein für gesteuerte geweberegenerationen
US7033611B2 (en) 2001-02-23 2006-04-25 Biora Bioex Ab Matrix protein compositions for guided connective tissue growth
RU2295972C2 (ru) * 2001-09-14 2007-03-27 Биора Биоэкс Аб Композиции на основе белков матрикса зубной эмали для модуляции иммунного ответа
KR100934411B1 (ko) 2001-09-14 2009-12-29 바이오라 바이오엑스 에이비 면역반응을 조절하기 위한 에나멜 기질 단백질 조성물
KR100450146B1 (ko) * 2002-02-19 2004-09-30 정필훈 발치된 치아로부터 치아 단백질의 추출방법과 그의이용방법
KR101123113B1 (ko) * 2002-07-29 2012-03-15 쎄라피콘 에스.알.엘. 코 펩티드 약학 제형
JP2004307454A (ja) 2003-02-21 2004-11-04 Seikagaku Kogyo Co Ltd 生理活性ペプチド及びこれを含有する薬剤
CA2589095C (en) 2004-12-10 2012-05-08 Straumann Holding Ag Protein formulation for administering an active enamel substance
EP1862170B1 (de) * 2004-12-10 2012-03-14 Straumann Holding AG Emailleformulierung mit Amelogenin
SE0403014D0 (sv) 2004-12-10 2004-12-10 Straumann Holding Ag New protein formulation
DK1931321T3 (en) 2005-08-31 2019-04-15 Abraxis Bioscience Llc COMPOSITIONS CONTAINING VERY WATER-SOLUBLE PHARMACEUTICAL AND ANTIMICROBIAL AGENTS
WO2011051457A2 (en) 2009-11-02 2011-05-05 Straumann Holding Ag Purified emd protein composition
WO2011073447A1 (en) * 2009-12-18 2011-06-23 Straumann Holding Ag Emd c-depleted
GB0922438D0 (en) 2009-12-22 2010-02-03 Ucl Business Plc Agents having tissue generative activity
KR101821842B1 (ko) 2010-10-15 2018-01-24 스트라우만 홀딩 에이쥐 Ｐｇａ를 포함하는 새로운 ｅｍｄ 제제
US20120294898A1 (en) * 2011-05-19 2012-11-22 Warsaw Orthopedic, Inc. Injectable dbm for soft tissue repair
EP2687224A1 (de) * 2012-07-19 2014-01-22 Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH Medikament zur Wundbehandlung
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
CN112915281B (zh) * 2021-03-12 2022-12-16 臻叶生物科技有限公司 一种无抗凝剂的prp生物膜制备装置及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454480B (sv) * 1986-09-25 1988-05-09 Lars Hammarstrom Bindningsinducerande komposition
SE461313B (sv) * 1988-03-17 1990-02-05 Biora Ab Bindningsinducerande komposition
DE69635081T2 (de) * 1995-07-13 2006-06-01 Biora Ab Schmelz-Matrix betreffende Polypeptide
BRPI9908182C1 (pt) * 1998-02-27 2021-05-25 Biora Ab composições de proteína de matriz para cura de feridas

Also Published As

Publication number Publication date
ATE247483T1 (de) 2003-09-15
NO20004282L (no) 2000-10-27
EP1059934B1 (de) 2002-07-24
CN1248734C (zh) 2006-04-05
AU740468B2 (en) 2001-11-08
JP5227428B2 (ja) 2013-07-03
DK1059934T3 (da) 2002-11-11
DE69910622T2 (de) 2004-06-17
EP1153610B1 (de) 2003-08-20
HUP0101710A2 (hu) 2001-09-28
EP1059934A2 (de) 2000-12-20
JP2007291115A (ja) 2007-11-08
DE69902234D1 (de) 2002-08-29
WO1999043344A2 (en) 1999-09-02
IS5591A (is) 2000-08-18
JP2011088927A (ja) 2011-05-06
IL137869A0 (en) 2001-10-31
JP5024866B2 (ja) 2012-09-12
CA2322215C (en) 2010-12-21
ATE220918T1 (de) 2002-08-15
ES2183510T3 (es) 2003-03-16
ES2204804T3 (es) 2004-05-01
PL343375A1 (en) 2001-08-13
CA2640994A1 (en) 1999-09-02
AU2436899A (en) 1999-09-15
PL202536B1 (pl) 2009-07-31
WO1999043344A3 (en) 1999-11-25
CN1297356A (zh) 2001-05-30
EP1153610A1 (de) 2001-11-14
CA2640994C (en) 2013-07-09
KR20010041408A (ko) 2001-05-15
DK1153610T3 (da) 2003-12-08
SK12362000A3 (sk) 2001-04-09
HK1030880A1 (en) 2001-05-25
CA2322215A1 (en) 1999-09-02
BR9908182A (pt) 2001-11-13
DE69910622D1 (de) 2003-09-25
NO20004282D0 (no) 2000-08-25

Similar Documents

Publication Publication Date Title
DE69902234T2 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
DE60117043D1 (de) Behandlung von mukositis
ES2140670T3 (es) Cicatrizacion de heridas.
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
WO2001041753A3 (en) Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds
DE69910202D1 (de) EGR-1 zur Herstellung eines Medikamentes zur Behandlung von Wunden
DK0821969T3 (da) Medicinsk sammensætning omfattende TCF-II
EP1361905B8 (de) Verwendung von matrixprotein für gesteuerte geweberegenerationen
BR0014751A (pt) Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto
UA42335A (uk) Спосіб лікування гнійних ран
ITPD920102A0 (it) Composizione farmaceutica utile per trattare malattie gastroenteriche,ferite e ustioni e come agente emostatico

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INSTITUT STRAUMANN AG, BASEL, CH

R082 Change of representative

Ref document number: 1059934

Country of ref document: EP

Representative=s name: PATENT- UND RECHTSANWAELTE KRAUS & WEISERT, DE